Why the study?
Does diuretic use improve morbidity and mortality outcomes in patients with heart failure?
Does diuretic use improve morbidity and mortality outcomes in patients with heart failure?
This review highlights the scarcity of prospective data regarding the impact of widely used diuretics on morbidity and mortality in heart failure.
Lacking prospective data precludes firm diuretic recommendations in HF; leaves open effects on morbidity and mortality.
Diuretics are frequently administered to relieve congestive symptoms in patients with heart failure (HF). Despite their widespread use, prospective data on the potential of diuretics to modulate HF-related morbidity and mortality are scarce. Diuretic efficacy may be limited by adverse neurohormonal activation and by "congestion-like" symptoms that may occur in the absence of fluid overload. Herein, we review the current knowledge on diuretic use and outcomes in HF.
No takes yet. Share an insight, caveat, or question.
Lueder et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: